[HTML][HTML] The world of protein acetylation

A Drazic, LM Myklebust, R Ree, T Arnesen - Biochimica et Biophysica Acta …, 2016 - Elsevier
Acetylation is one of the major post-translational protein modifications in the cell, with
manifold effects on the protein level as well as on the metabolome level. The acetyl group …

[HTML][HTML] Histone deacetylases and cancer

B Barneda-Zahonero, M Parra - Molecular oncology, 2012 - Elsevier
Reversible acetylation of histone and non-histone proteins is one of the most abundant post-
translational modifications in eukaryotic cells. Protein acetylation and deacetylation are …

Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed

BE Gryder, QH Sodji, AK Oyelere - Future medicinal chemistry, 2012 - Taylor & Francis
Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of
small-molecule therapeutics acting through the regulation of the acetylation states of histone …

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

O Khan, NB La Thangue - Immunology and cell biology, 2012 - Wiley Online Library
Reversible acetylation mediated by histone deacetylases (HDACs) influences a broad
repertoire of physiological processes, many of which are aberrantly controlled in tumor cells …

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

K Keller, M Jung - Epigenetic Therapy of Cancer: Preclinical Models and …, 2013 - Springer
Histone deacetylases are key enzymes of epigenetic regulation and are therefore involved
in crucial cellular events like transcription, differentiation, apoptosis and cell division. The …

Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer

A Aghdassi, M Sendler, A Guenther, J Mayerle… - Gut, 2012 - gut.bmj.com
Objective Pancreatic cancer is characterised by invasive tumour spread and early
metastasis formation. During epithelial–mesenchymal transition, loss of the cell adhesion …

Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer-overexpression of HDAC2 and HDAC3 is associated with clinicopathological …

BM Müller, L Jana, A Kasajima, A Lehmann, J Prinzler… - BMC cancer, 2013 - Springer
Background In breast cancer, the role of epigenetic alterations including modifications of the
acetylation status of histones in carcinogenesis has been an important research focus …

Multiple myeloma therapy: emerging trends and challenges

D Dima, D Jiang, DJ Singh, M Hasipek, HS Shah… - Cancers, 2022 - mdpi.com
Simple Summary Multiple myeloma (MM) is a frequent hematological malignancy
characterized by the uncontrolled growth of clonal plasma cells, primarily in the bone …

Targeting the DNA Damage Response in OSCC with TP53 Mutations

A Lindemann, H Takahashi, AA Patel… - Journal of dental …, 2018 - journals.sagepub.com
Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer worldwide
and in the United States. OSCC remains a major cause of morbidity and mortality in patients …

Histone deacetylases: structural determinants of inhibitor selectivity

C Micelli, G Rastelli - Drug discovery today, 2015 - Elsevier
Highlights•Isoform-selective histone deacetylase inhibitors are highly desirable.•Crystal
structure information provides important insights into inhibitor selectivity.•We review the …